1. Home
  2. Benzenamine, 2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]-

Contact Angene

Tel: +852 8191 6999

Email: [email protected]

Brc1cnc(nc1)C
Pyrimidine, 5-bromo-2-methyl-
CCCP1(=O)OP(=O)(CCC)OP(=O)(O1)CCC
1,3,5,2,4,6-Trioxatriphosphorinane, 2,4,6-tripropyl-, 2,4,6-trioxide
CC1(C)OB(OC1(C)C)B1OC(C(O1)(C)C)(C)C
2,2'-Bi-1,3,2-dioxaborolane, 4,4,4',4',5,5,5',5'-octamethyl-
O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.O=C(C=Cc1ccccc1)C=Cc1ccccc1.[Pd].[Pd]
Tris(dibenzylideneacetone)dipalladium
C1CCC(CC1)P(C1CCCCC1)C1CCCCC1.Cc1cc(C)c(c(c1)C)N1CCN(C1=[Ru](=Cc1ccccc1)(Cl)Cl)c1c(C)cc(cc1C)C
Ruthenium,[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro(phenylmethylene)(tricyclohexylphosphine)-, (SP-5-41)-

Benzenamine, 2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]-

COc1cc(ccc1N)OC1CCN(CC1)C Request for Quotation
Chemical Name: Benzenamine, 2-methoxy-4-[(1-methyl-4-piperidinyl)oxy]-
CAS Number: 761440-71-5
Product Number: AG0057T9(AGN-PC-0AL4K0)
Synonyms:
MDL No:
Molecular Formula: C13H20N2O2
Molecular Weight: 236.3101

Identification/Properties

Properties
Storage:
Inert atmosphere;Room Temperature;
Form:
Solid

Safety Information

GHS Pictogram:
Signal Word:
Warning
UN#:
N/A
Hazard Statements:
H302-H312-H332
Precautionary Statements:
P280
Class:
N/A
Packing Group:
N/A

NMR Spectrum

Other Analytical Data

Request for Quotation

Customer Feedback

Chemical Structure


2-Methoxy-4-((1-methylpiperidin-4-yl)oxy)aniline serves as a valuable building block in chemical synthesis, particularly in the development of pharmaceuticals and bioactive compounds. Its unique structure and reactivity make it an essential intermediate in the creation of various organic molecules. This compound can be utilized as a key component in the construction of heterocyclic rings, which are common motifs found in many biologically active substances. Additionally, its presence in the synthesis of drug candidates highlights its importance in medicinal chemistry research, showcasing its potential to contribute to the discovery of new therapeutic agents.